Request to Join

Win a chance to present your idea before an audience of investors, biotech and medical device companies! Just submit your ideas using the form below and remember, the winners are chosen by crowd voting so be sure to let all your colleagues and friends know to vote for you.

Win a chance to present your idea before an audience of investors, biotech and medical device companies! Just submit your ideas using the form below and remember, the winners are chosen by crowd voting so be sure to let all your colleagues and friends know to vote for you.

Depression costs our healthcare system $100Bn per year, and drugs are not the answer. Antidepressants are expensive and rife with terrible side effects. The powerful alternative to drugs is bright light therapy (BLT), which is clinically shown to be as effective as drugs, but works 4x faster with no side effects.
SunSprite is a BLT patient engagement solution for depression. It is the only wearable of its kind.
Early SunSprite pilots show 82% patient engagement (vs antidepressants’ 50%) and 73% patient health improvement. Beyond better outcomes and cost savings, SunSprite allows non-MDs (e.g., social workers, nurses) a more active role in treatment.
BLT’s effectiveness is compounded when combined with exercise, which is proven to stimulate brain function, increase energy, and boost mood.
By piloting SunSprite with Misfit, we can create a depression solution that engages patients, improves outcomes, and reduces cost in a tech-forward world.

Total Score

Register to vote

Easy one-click social registration

We only receive the minimum information necessary to verify your account.
We never get access to your friends/contacts or your profile, and we never post on your behalf.
Your social account is used for logging in only.

Please indicate that you accept the privacy policy and terms of service

In order to ensure a fair voting process and to make sure that no one votes more than once,
we ask that you register either with a social networking account (easiest, only requires one click)
or by registering with your email address (this will require you to click on a verification email that we will send you).

The American Psychiatric Association recommends continuing antidepressant medication during two phases of treatment: the acute phase (6-12 weeks), where patient experiences serious symptoms most in...
Read More